Molecular Hydrogen Protects Against Ischemia-reperfusion Injury in a Mouse Fatty Liver Model Via Regulating HO-1 and Sirt1 Expression
Authors
Affiliations
Fatty liver has lower tolerance against ischemia-reperfusion (I/R) injury in liver operations, including liver transplantation. Seeking to ameliorate liver injury following I/R in fatty liver, we examined the protective effect of hydrogen (H) saline on I/R liver injury in a methionine and choline-deficient plus high fat (MCDHF) diet-induced fatty liver mouse model. Saline containing 7 ppm H was administrated during the process of I/R. Livers were obtained and analyzed. Primary hepatocytes and Kupffer cells (KCs) were obtained from fatty liver and subjected to hypoxia/reoxygenation. Apoptosis-related proteins and components of the signaling pathway were analyzed after treatment with hydrogen gas. The MCDHF I/R group showed higher levels of AST and ALT in serum, TUNEL-positive apoptotic cells, F4/80 immunopositive cells, mRNA levels of inflammatory cytokines, constituents of the signaling pathway, pro-apoptotic molecules in liver, and KCs and/or primary hepatocytes, compared to the control group. In contrast, H treatment significantly suppressed the signs of I/R injury in fatty liver. Moreover, the expression of Bcl-2, HO-1, and Sirt1 in liver, KCs, and hepatocytes by hydrogen gas were increased, whereas caspase activation, Bax, and acetylation of p53 were suppressed by hydrogen gas. These results demonstrated that H treatment ameliorated I/R liver injury in a fatty liver model by reducing hepatocyte apoptosis, inhibiting macrophage activation and inflammatory cytokines, and inducing HO-1 and Sirt1 expression. Taken togather, treatment with H saline may have a protective effect and safe therapeutic activity during I/R events, such as in liver transplantation with fatty liver.
Zhang L, Zhao F, Li Y, Song Z, Hu L, Li Y Redox Biol. 2025; 79():103472.
PMID: 39752998 PMC: 11754494. DOI: 10.1016/j.redox.2024.103472.
The Protective Role of Molecular Hydrogen in Ischemia/Reperfusion Injury.
Kura B, Slezak J Int J Mol Sci. 2024; 25(14).
PMID: 39063126 PMC: 11276695. DOI: 10.3390/ijms25147884.
Mesenchymal Stem Cell Priming: Potential Benefits of Administration of Molecular Hydrogen.
Artamonov M, LeBaron T, Pyatakovich F, Minenko I Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675429 PMC: 11054387. DOI: 10.3390/ph17040469.
Mitochondria: one of the vital hubs for molecular hydrogen's biological functions.
Zhang X, Xie F, Ma S, Ma C, Jiang X, Yi Y Front Cell Dev Biol. 2023; 11:1283820.
PMID: 38020926 PMC: 10662307. DOI: 10.3389/fcell.2023.1283820.
Xue X, Xi W, Li W, Xiao J, Wang Z, Zhang Y ESC Heart Fail. 2023; 10(5):3077-3090.
PMID: 37602925 PMC: 10567641. DOI: 10.1002/ehf2.14492.